October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Highlights of the RADIOSA phase II trial presented at ESTRO24
Jul 5, 2024, 01:49

Highlights of the RADIOSA phase II trial presented at ESTRO24

European Society for Radiotherapy and Oncology (ESTRO) shared a paper on LinkedIn:

“Highlights of the RADIOSA phase II trial presented at ESTRO24: SBRT + short-term ADT significantly improves outcomes in oligorecurrent hormone-sensitive prostate cancer patients.

Report by Simon Spohn.”

Read further.
Source: ESTRO/LinkedIn

.